Scientists discover brain mechanism that drives us to eat glucose
Glucose is a component of carbohydrates, and the main energy source used by brain cells.
Dec 8, 2014
11
0
Glucose is a component of carbohydrates, and the main energy source used by brain cells.
Dec 8, 2014
11
0
Up to 5.3 million Americans currently have Alzheimer's disease, according to the U.S. Centers for Disease Control and Prevention, a number that is expected to triple by 2050 due to the aging of the population.
Dec 3, 2014
0
0
EPFL scientists have shown that a receptor activated by bile acids can reduce fat-tissue inflammation and insulin resistance in obesity-linked diabetes.
Nov 3, 2014
0
0
Approximately 1 billion people worldwide have non-alcoholic fatty liver disease (NAFLD). Individuals with this disease have an increased risk of type 2 diabetes, obesity, and kidney disease. It is not clear how this disease ...
Oct 27, 2014
0
0
Tooth decay is one of the most common chronic diseases worldwide. While oral hygiene and dietary choices promote tooth decay, genetics are also a factor in cavity formation.
Oct 27, 2014
0
0
Almost 40 million people worldwide live with HIV/AIDS, with an estimated 2.5 million new cases per year. Therefore, there has been a large global effort to develop an effective vaccine against the virus. HIV-1 vaccine development ...
Oct 1, 2014
0
0
Stroke is one of the leading causes of death worldwide. While many lines of evidence suggest that stroke risk is heritable, only a small number of genes associated with stroke have been identified.
Sep 24, 2014
0
0
Brain activity can be used to tell whether someone recognizes details they encountered in normal, daily life, which may have implications for criminal investigations and use in courtrooms, new research shows.
Sep 23, 2014
0
0
Researchers at Johns Hopkins have identified a highly sensitive means of analyzing very tiny amounts of DNA. The discovery, they say, could increase the ability of forensic scientists to match genetic material in some criminal ...
Sep 15, 2014
0
0
Gilead Sciences has reached a deal with several generic drugmakers to produce a cheaper version of its popular, $1,000-per-pill hepatitis C drug Sovaldi for use in developing countries.
Sep 15, 2014
0
0